摘要
目的观察通心络胶囊对急性脑梗死患者的临床疗效。方法收集急性脑梗死住院患者100例,随机分为通心络组和对照组,随访3个月,通过记录日常生活活动能力(ADL)、改良Rankin量表(mRS)和死亡评价脑梗死患者近期预后。结果通心络组脑梗死患者3个月后ADL、mRS好于对照组,差别有统计学意义(P<0.05)。结论配合西药应用通心络胶囊能改善急性脑梗死患者3个月后的预后。
Objective To observe the effect of tongxinluo capsule on the short-term prognosis of patients with acute cerebral infarction. Methods One hundred patients with acute cerebral infarction were randomized to either tongxinluo or placebo group. All patients were followed up prospectively for 3 months. The death events, value of activities of daily living （ADL） and modify Rankin scale （mRS） were evaluated. Results Tongxinluo group was associated with good outcome by ADL and mRS. Those outcomes were significantly different between two groups. Conclusion Combined with medicine, tongxinluo capsule can improve the prognosis in patients with acute cerebral infarction 3 months later.
出处
《中国实用神经疾病杂志》
2010年第18期20-21,共2页
Chinese Journal of Practical Nervous Diseases
关键词
通心络胶囊
脑梗死
预后
Tongxinluo capsule
Cerebral infarction
Prognosis
